Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. | Director | Common Stock | 1.43 M | $25 M | $17.50 | Jan 9, 2024 | Indirect |
Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 25.1 K | May 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | May 22, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Jan 9, 2024 | 2 | $30 M | 4 | Jan 11, 2024 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 25, 2023 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 27, 2021 | Director, 10%+ Owner |